findmyKOL
Clinical trialNCT02597712CompletedPhase 2Interventional

YF476 in Barrett's Esophagus

SponsorTrio Medicines Ltd.Enrollment27Barrett's Esophagus
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • Mrc Cancer Unit, University of Cambridge

    Cambridge, Cambridgeshire, United Kingdom

United States
  • Columbia University, Division of Digestive & Liver Diseases

    New York, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 May 2013
Primary completion
28 Nov 2017
Completion
27 Dec 2017
Last update posted
12 Apr 2021
Registered enrollment
27
Registry id
NCT02597712

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.